BCR and chronic myelogenous leukemia, BCR-ABL1 positive: As a group, these results demonstrated that the expression of phosphor-BCR/ABL and its downstream signaling molecules in CML cells were down-regulated after Ab@Tf-Cou6-PLGA NPs treatment.